Poor predictive value of breath hydrogen response for probiotic effects in IBS

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 12, 2015, Pages 1731-1739

  Yao, Chu K ^a   Barrett, Jacqueline S ^a   Philpott, Hamish ^b   Chung, Alvin R T ^b   van Langenberg, Daniel ^b   Garg, Mayur ^b   Gibson, Peter R ^a  

^a MONASH UNIVERSITY   (Australia)

^b BOX HILL HOSPITAL   (Australia)

Author keywords

Irritable bowel syndrome; Lactulose breath test; Probiotic; SIBO

Indexed keywords

BIOLOGICAL MARKER; HYDROGEN; LACTULOSE; PROBIOTIC AGENT;

ADULT; AGED; BREATH ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; BREATH TESTS; DOUBLE-BLIND METHOD; FEMALE; GASTRIC EMPTYING; HUMANS; HYDROGEN; IRRITABLE BOWEL SYNDROME; LACTULOSE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBIOTICS; YOUNG ADULT;

EID: 84954415381     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13015     Document Type: Article

References (25)

1. Simren M, Barbara G, Flint HJ et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013; 62: 159-76.
2. Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. Utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am. J. Gastroenterol. 2009; 104: 1033-49.
3. Whelan K, Quigley EMM. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr. Opin. Gastroenterol. 2013; 29: 184-9.
4. Attar A, Flourié B, Rambaud J, Franchisseur C, Ruszniewski P, Bouhnik Y. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology. 1999; 117: 794-7.
5. Cuoco L, Salvagnini M. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin. Minerva Gastroenterol. Dietol. 2006; 52: 89-95.
6. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study. Am. J. Gastroenterol.. 2003; 98: 412-9.
7. Pimentel M, Constantino T, Kong Y, Bajwa M, Rezaei A, Park S. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig. Dis. Sci. 2004; 49: 73-7.
8. Posserud I, Stotzer P-O, Björnsson ES, Abrahamsson H, Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007; 56: 802-8.
9. Gibson PR, Barrett JS. The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders. Nutrition. 2010; 26: 1038-43.
10. Grace E, Shaw C, Whelan K, Andreyev HJ. Review article: small intestinal bacterial overgrowth-prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment. Pharmacol. Ther. 2013; 38: 674-88.
11. Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011; 60: 334-40.
12. Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. Probiotic beverage containing Lactobacilluscasei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can. J. Gastroenterol. 2003; 17: 655-9.
13. Barrett JS, Canale KE, Gearry RB, Irving PM, Gibson PR. Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastro. 2008; 14: 5020-4.
14. Braden B, Adams S, Duan L-P et al. The [13C] acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology. 1995; 108: 1048-55.
15. Bengtsson M, Ohlsson B, Ulander K. Development and psychometric testing of the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2007; 7: 16-26.
16. Biesiekierski JR, Newnham ED, Irving PM, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am. J. Gastroenterol. 2011.
17. Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG. Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity following dietary reduction of low-fermentable, poorly-absorbed, short-chain carbohydrates. Gastroenterology. 2013.
18. Ford AC, Spiegel BMR, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 2009; 7: 1279-86.
19. Bures J, Cyrany J, Kohoutova D et al. Small intestinal bacterial overgrowth syndrome. World J Gastro. 2010; 16: 2978.
20. Camboni G, Basilisco G, Bozzani A, Bianchi PA. Repeatability of lactulose hydrogen breath test in subjects with normal or prolonged orocecal transit. Dig. Dis. Sci. 1988; 33: 1525-7.
21. Ladas S, Latoufis C, Giannopoulou H, Hatziioannou J, Raptis S. Reproducible lactulose hydrogen breath test as a measure of mouth-to-cecum transit time. Dig. Dis. Sci. 1989; 34: 919-24.
22. Barrett JS, Canale KEK, Gearry RB, Irving PM, Gibson PR. Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J. Gastroenterol. 2008; 14: 5020-4.
23. Gabrielli M, Lauritano EC, Scarpellini E et al.Bacillusclausii as a treatment of small intestinal bacterial overgrowth. Am. J. Gastroenterol. 2009; 104: 1327-8.
24. O'Sullivan MA, O'Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig. Liver Dis.. 2000; 32: 294-301.
25. Dapoigny M, Piche T, Ducrotte P, Lunaud B, Cardot JM, Bernalier-Donadille A. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study. World J. Gastroenterol. 2012; 18: 2067-75.